Managing anaemia in critically ill adults

BMJ (Online)

Volumn 341, Issue 7772, 2010, Pages 547-551

  Walsh, Timothy S ^a   Wyncoll, Duncan L A ^b   Stanworth, Simon J ^c  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; INOTROPIC AGENT; IRON; RECOMBINANT ERYTHROPOIETIN;

ACUTE CORONARY SYNDROME; ADULT DISEASE; ANEMIA; BLEEDING; BLOOD DONOR; CLINICAL TRIAL; CRITICALLY ILL PATIENT; ERYTHROCYTE TRANSFUSION; FERRITIN BLOOD LEVEL; HEART DISEASE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN TRANSFUSION; HEMOLYSIS; HOSPITAL INFECTION; HUMAN; IRON THERAPY; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; LACTIC ACIDOSIS; LIVER DISEASE; MEDICAL DECISION MAKING; MYELODYSPLASTIC SYNDROME; NUTRITIONAL DEFICIENCY; OXYGEN SUPPLY; PRIORITY JOURNAL; REVIEW; SEPSIS; SYSTEMATIC REVIEW; TRANSFUSION;

ACUTE CORONARY SYNDROME; ADULT; ANEMIA; BLOOD TRANSFUSION; CHRONIC DISEASE; CRITICAL ILLNESS; ERYTHROCYTE TRANSFUSION; HEMOGLOBINS; HUMANS; MYOCARDIAL ISCHEMIA; NERVOUS SYSTEM DISEASES; RISK FACTORS; SEPSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77956512838     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c4408     Document Type: Review

References (27)

1. Walsh TS, Garrioch M, Maciver C, Lee RJ, MacKirdy F, McClelland DB, et al. Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion 2004;44:1405-11.
2. Madjdpour C, Spahn DR. Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br J Anaesth 2005;95:33-42. (Pubitemid 40903884)
3. Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet 2007;370:415-26.
4. Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med 2009;37:3124-57.
5. Walsh TS, Saleh EE. Anaemia during critical illness. Br J Anaesth 2006;97:278-91.
6. Carson JL, Reynolds RC, Klein HG. Bad bad blood? Crit Care Med 2008;36:2707-8.
7. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002;288:1499-507.
8. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, et al. The CRIT study: anemia and blood transfusion in the critically ill - current clinical practice in the United States. Crit Care Med 2004;32:39-52.
9. Nguyen BV, Bota DP, Melot C, Vincent JL. Time course of hemoglobin concentrations in nonbleeding intensive care unit patients. Crit Care Med 2003;31:406-10.
10. Von Ahsen N, Muller C, Serke S, Frei U, Eckardt KU. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 1999;27:2630-9.
11. Scharte M, Fink MP. Red blood cell physiology in critical illness. Crit Care Med 2003;31:S651-7.
12. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-23.
13. Piagnerelli M, Boudjeltia KZ, Vanhaeverbeek M, Vincent JL. Red blood cell rheology in sepsis. Intensive Care Med 2003;29:1052-61. (Pubitemid 36918545)
14. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008;36:2667-74.
15. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409-17.
16. Cardigan R, Williamson LM. Production and storage of blood components. In: Practical transfusion medicine. 3rd ed. Blackwell publishing, 2009:209-24.
17. Zimrin AB, Hess JR. Current issues relating to the transfusion of stored red blood cells. Vox Sanguinis 2009;96:93-103.
18. Wells AW, Mounter PJ, Chapman CE, Stainsby D, Wallis JP. Where does blood go? Prospective observational study of red cell transfusion in north England. BMJ 2002;325:803-4.
19. Mukhopadhyay A, Yip HS, Prabhuswamy D, Chan YH, Phua J, Lim TK, et al. The use of a blood conservation device to reduce red blood cell transfusion requirements: before and after study. Crit Care 2010;14:R7.
20. Weiskopf RB, Viele MK, Feiner J, Kelley S, Lieberman J, Noorani M, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998;279:217-21.
21. Hill SR, Carless PA, Henry DA, Carson JL, Hebert PC, Henderson KM, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2002;2:CD002042.
22. Gerber DR. Transfusion of packed red blood cells in patients with ischemic heart disease. Crit Care Med 2008;36:1068-74.
23. Hebert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001;29:227-34.
24. Bassand JP. Bleeding and transfusion in acute coronary syndromes: a shift in the paradigm. Heart 2008;94:661-6.
25. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.
26. Leal-Noval SR, Munoz-Gomez M, Murillo-Cabezas F. Optimal hemoglobin concentration in patients with subarachnoid hemorrhage, acute ischemic stroke and traumatic brain injury. Curr Opin Crit Care 2008;14:156-62. (Pubitemid 351498780)
27. Corwin HL Gettinger A, Fabian TC, et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 2007;357:965-76.